An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.

An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.

Development of a globally effective HIV-1 vaccine will need to encompass Nigeria, one of the hardest hit areas, with an estimated 3.2 million people living with HIV. This cross-sectional Institutional Review Board (IRB) approved study was conducted in 2009-12 at four market sites and two highway set...

Full description

Bibliographic Details
Main Authors: Ogbonnaya S Njoku, Mark M Manak, Robert J O'Connell, Ashley L W Shutt, Jennifer A Malia, Richard A Heipertz, Sodsai Tovanabutra, Mark J Milazzo, Gideon Akindiran Akintunde, Abraham S Alabi, Aminu Suleiman, Amos A Ogundeji, Terfa S Kene, Robbie Nelson, Ojor R Ayemoba, Darrell E Singer, Merlin L Robb, Sheila A Peel, Nelson L Michael
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5147844?pdf=render

Internet

http://europepmc.org/articles/PMC5147844?pdf=render

Similar Items